Quarter Period Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7733914

Concept 2017-06-01 to
2017-08-31
2016-06-01 to
2016-08-31
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
663,682,000 JPY
664,191,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
39,633,000 JPY
-290,575,000 JPY
Foreign currency translation adjustment
18,551,000 JPY
-151,495,000 JPY
Remeasurements of defined benefit plans, net of tax
1,062,000 JPY
43,660,000 JPY
Other comprehensive income
59,246,000 JPY
-398,410,000 JPY
Comprehensive income
722,928,000 JPY
265,781,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
726,935,000 JPY
318,155,000 JPY
Comprehensive income attributable to non-controlling interests
-4,006,000 JPY
-52,373,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.